Invasive candidiasis: current clinical challenges and unmet needs in adult populations

AbstractInvasive candidiasis (IC) is a serious infection caused by severalCandida species, and the most common fungal disease in hospitals in high-income countries. Despite overall improvements in health systems and ICU care in the last few decades, as well as the development of different antifungals and microbiological techniques, mortality rates in IC have not substantially improved. The aim of this review is to summarize the main issues underlying the management of adults affected by IC, focusing on specific forms of the infection: IC developed by ICU patients, IC observed in haematological patients, breakthrough candidaemia, sanctuary site candidiasis, intra-abdominal infections and other challenging infections.Several key challenges need to be tackled to improve the clinical management and outcomes of IC patients. These include the lack of global epidemiological data for IC, the limitations of the diagnostic tests and risk scoring tools currently available, the absence of standardized effectiveness outcomes and long-term data for IC, the timing for the initiation of antifungal therapy and the limited recommendations on the optimal step-down therapy from echinocandins to azoles or the total duration of therapy.The availability of new compounds may overcome some of the challenges identified and increase the existing options for management of chronicCandida infections and ambulant patient treatments. However, early identification of patients that require antifungal therapy ...
Source: Journal of Antimicrobial Chemotherapy - Category: Microbiology Source Type: research